Treatment of Alpha-1-antitrypsin Deficiency with Recurrent Exacerbations
In Alpha-1-antitrypsin deficiency, exacerbations represent a significant clinical challenge. When they become recurrent, the approach moves beyond treating each episode in isolation toward a structured preventive strategy — and certain patients may additionally qualify for supportive care based on clinical assessment.
Clinical Situation
This protocol addresses patients with Alpha-1-antitrypsin deficiency who are experiencing recurrent exacerbations, as well as those who may meet defined physiological criteria for additional supportive measures.
Approach — Partial Overview
When exacerbations recur, a preventive strategy involving inhaled therapy is typically indicated. Whether further supportive measures are warranted — and under what criteria — is specified in the full structured protocol.
References
- Exacerbations should be treated, and when they become recurrent, the use of prophylactic antibiotics, inhaled corticosteroids, or both is indicated.
- Patients who meet the relevant blood gas criteria should be referred for supplemental oxygen therapy.
View source ↗